This inherited disease gradually destroys brain cells, causing a progressive, severe deterioration in physical and mental functions — and it's very difficult to slow or address. Now, researchers from the South Carolina School of Medicine have found an unexpected therapy to help: the amino acid acetyl L-carnitine.
The researchers looked at 23 patients with Huntington's cholera and found that 26% of them had low levels of carnitine. They helped the deficient patients for seven months and saw "improvements in motor, cognitive and behavioral measures."
"Our findings suggest that Huntington's disease patients with (low carnitine levels) may benefit from low-dose levocarnitine supplementation," concluded the researchers in Neurological Science.
Read more at NCBI.com.
"Serum carnitine levels and levocarnitine supplementation in institutionalized Huntington's disease patients," Cuturic M, Abramson RK, et al, Neurol Sci, 2012 Feb 1; [Epub ahead of print].
Jacob Teitelbaum, M.D. is one of the world's leading integrative medical authorities on fibromyalgia and chronic fatigue. He is the lead author of four research studies on their treatments, and has published numerous health & wellness books, including the bestseller on fibromyalgia and chronic fatigue syndrome From Fatigued to Fantastic! and his newer The Fatigue and Fibromyalgia Solution. Dr. Teitelbaum is one of the most frequently quoted fibromyalgia experts in the world and appears often as a guest on news and talk shows nationwide including Good Morning America, The Dr. Oz Show, Oprah & Friends, CNN, and Fox News Health.